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Abstract
Organisms have evolved numerous specialized molecules for constantly responding to
environmental changes. Examples of such molecules are the light-driven proton-pump rhodopsins,
such as bacteriorhodopsin (BR) and cruxrhodopsin (cR), and the carotenoid pigments, such as
retinal and bacterioruberin. In halophilic Archaea, retinal can covalently bind bacterioopsin (BO)
and cruxopsin (CO) to form the corresponding protein complexes, and its biosynthesis is indirectly
controlled by the activity of the lycopene elongase (Lye) enzyme, which converts lycopene, a
retinal precursor, to a form of bacterioruberin. Interestingly, opsins were shown to inhibit the
activity of Lye, thereby promoting retinal biosynthesis and indirectly regulating the apoproteincofactor stoichiometry. This is a newly described regulatory mechanism, and, considering the
importance of the problem it addresses, we set to determine the protein domains involved in the
opsin-Lye inhibition. Using a fusion protein approach, we determined that a 52 amino acid domain
in Lye, a 2 amino acid section in BO, and 34 and 43 amino acid regions in CO are required for the
studied interaction. Furthermore, we compared the proteins’ tertiary structures and found
supporting evidence for the validity of our identified regions and for the localization of the
interaction at the interface of the lipid bilayer and the cytoplasm. Future studies could further
investigate this recently discovered regulatory mechanism by identifying the participating protein
amino acids more precisely and by searching for homologous domains in other biological systems.
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Introduction
Environments are constantly changing, and, in order to survive, organisms have to respond to
these changes. To achieve this function, many life forms have evolved specialized molecules to
mediate environmental interactions. Two types of such molecules are opsins and carotenoids.

Opsins
Opsins are light sensing proteins found in all domains of life: Archaea, Bacteria, and Eukarya1.
Their structure consists of seven transmembrane (TM) α-helices that form a binding pocket for a
light-reactive chromophore, which confers the protein’s light sensitivity. The chromophore is a
vitamin-A based retinaldehyde that forms a covalent bond to a lysine residue from the seventh TM
helix (Figure 1). These proteins have been classified in two functionally similar families, type I
and type II, based on primary sequence alignments. Type I opsins (microbial opsins) are found in
both prokaryotes and eukaryotes, while type II opsins are present only in higher eukaryotes2,3.

Figure 1. Representation of the general structure of opsins4. Highlighted lysine is the
retinal binding residue.
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On Earth, most life is ultimately dependent on light energy, making light one of the most
important environmental signals5. As such, most organisms require light-sensing molecules for
either energy conversion or signal transduction. Opsins can perform both these functions by acting
as G protein-coupled receptors (GPCR) (type II opsins involved in visual perception and circadian
rhythms), photoreceptors (type I opsins: sensory rhodopsins I and II), or light-driven ion pumps
(type I opsins: bacteriorhodopsin, cruxrhodopsin)6,7.
Bacteriorhodopsin (BR) was the first discovered microbial opsin, and it is produced by the
halophilic Archaeon Halobacterium salinarum3,8. BR is a complex consisting of the bacterioopsin
(BO) apoprotein covalently bound to the retinal cofactor. It is a small (26 kDa) 7-TM light-driven
ion pump that uses the light-induced photoisomerization of all-trans retinal to 13-cis retinal to
generate a proton gradient. The gradient is used for the ATP synthase catalyzed conversion of ADP
to ATP and for other functions such as active transport and flagellar rotation 9–11. In H. salinarum,
BR is used for energy conversion when oxygen levels are too low to sustain aerobic respiration12.
The archaeal opsin cruxrhodopsin (cR), a homolog of BR, generates a proton gradient in a
related halophilic Archaeon, Haloarcula vallismortis13,14. However, despite this primary function
similarity, there is only 48-54% primary sequence identity between the two opsins, which raises
the possibility that the two proteins have other, different regulatory functions. Evidence of this
possibility comes from the recently resolved crystal structure of cR which displays several
structural differences from BR15.
BR is a stable protein over a wide range of temperature, pH, and salt concentrations. The
stability of this opsin along with its light-sensing function have made it the subject of many
applications in biology and biotechnology16–18. Some of these applications include:
optogenetics19,20, light sensors21–23, data storage24,25, and artificial retinal implants26,27. cR has not
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been studied as extensively as BR, but due to the shared light-sensing property, this protein has
also been used in neuronal silencing28,29. Due to the large number of applications for opsins, there
is currently an active interest to discover more about their regulation and functions in their native
organisms.

Carotenoids
Carotenoids are organic pigments synthesized by archaea, bacteria, fungi, plants, and some
animals (aphids and spider mites)30,31. Many life forms produce carotenoids for their roles in a
wide range of processes from UV protection and free radical defense to membrane stabilization
and photosynthesis32–37. One of these carotenoids is bacterioruberin, a C50 pink-colored pigment
found in various species of microbes, whose function still remains widely unknown.
There have been many studies aimed at discovering the role of bacterioruberin in microbial
organisms, but little agreement has been reached due to contradictory results. Some experiments
showed that bacterioruberin is involved in DNA protection against UV damage, and that its
biosynthesis is enhanced by light exposure32,38. However, preliminary results (Peck, unpublished)
suggest that, in Haloferax volcanii, there is no correlation between bacterioruberin production and
UV cytotoxicity protection. Similarly, recent results (Peck, unpublished) indicate that the presence
of bacterioruberin has no effect on osmotic stress resistance. This finding is contrary to previous
studies, which proposed that bacterioruberin plays a role in osmotic shock protection, on the basis
of data showing that this carotenoid reinforces membrane structure35.
While there is currently no convincing information on the function of bacterioruberin in the
microbial cell, this carotenoid and many others have been used in the food, cosmetics and
pharmaceutical industries for their coloring, antioxidant, and potential anti-cancer properties39–41.
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For example, recent studies have reported that carotenoids have a significant antiproliferative
activity against HepG2 human cell cancer lines, and there have been patents filed for the use of
halobacteria extracts as tumor reduction treatments42. Moreover, bacterioruberin was shown to
have a significantly higher free-radical scavenging capacity than β-carotene, a potent antioxidant43.
Another important role of carotenoids is their function as cofactors for various proteins
involved in many processes like gas transport, energy conservation, light-sensing and signal
transduction. While these protein complexes are of large importance for the homeostasis of an
organism, little is known about how cofactor biosynthesis and apoprotein expression are
coordinated to achieve an appropriate stoichiometry for a functional complex44. When this optimal
ratio of apoprotein to cofactor is not achieved, either of the molecules can accumulate and lead to
pathologies like porphyria (heme precursors accumulation) and retinitis pigmentosa (opsins
aggregation)45,46. Motivated by the importance of an optimal ratio of protein complex components,
we used rhodopsins as model proteins to study the mechanisms involved in regulating cofactor
biosynthesis and apoprotein expression that lead to the formation of functional complexes.

Opsins and carotenoids in halophilic Archaea
In its native organism, H. salinarum, bacterioopsin (BO) binds retinal in a 1:1 stoichiometry to
form a light-driven proton complex (BR)47. Retinal, the cofactor, is synthesized in a multi-step
process from a geranylgeranyl pyrophosphate precursor (Figure 2)48. During low-oxygen
conditions, H. salinarum can increase BR biosynthesis up to 50-fold in only a few hours of
growth49. This BR induction requires a corresponding increase in the production of both apoprotein
(BO) and cofactor (retinal), which is achieved by higher transcription levels of the BO gene (bop)
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and of other genes encoding retinal biosynthetic enzymes50. However, this does not fully explain
how the appropriate stoichiometry between BO and retinal is maintained.

Figure 2. Proposed pathway for retinal and bacterioruberin biosynthesis in H. salinarum44

Interestingly, previous results suggest that the BO apoprotein itself plays an important role in
regulating the production of the retinal cofactor. When not bound to retinal, BO inhibits the activity
of lycopene elongase (Lye), an enzyme that catalyzes the committed step in the synthesis of
bacterioruberin (Figure 2). Since bacterioruberin has common precursors with retinal, the
inhibition of Lye by BO likely acts to promote retinal biosynthesis at the expense of
bacterioruberin biosynthesis. Based on this observation and other unpublished data, it has been
proposed that BO regulates retinal production through a previously unknown regulatory
mechanism that involves a transient interaction between BO and Lye44.
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Furthermore, this interaction between Lye and BO seems to be a specific one. For instance, the
Lye homolog of H. volcanii, a microbe closely related to H. salinarum that does not produce any
opsins, is not inhibited by BO, despite a 65% primary sequence identity between the two Lye
proteins44. Similarly, CO, which shares a 53% primary sequence identity with BO, can inhibit the
function of H. vallismortis Lye, but has no effect on H. salinarum Lye (Peck et al., submitted).
This specificity suggests that the opsins experienced selection, which was likely driven by an
advantage conferred by the ability to regulate carotenoid biosynthesis through Lye inhibition. The
goal of this study was to further characterize the newly described mechanism by determining the
protein domains involved in the observed inhibitory interaction, which may provide important
insights into cofactor biosynthesis regulation in other biological systems.

Summary of results
Here, we present results that identify the Lye amino acid sequence required for the protein’s
inhibition by BO. This identified region is largely conserved between the two Lye homologs, with
the exception of small sections of disordered structure, which may be responsible for the
interaction with BO. We also present a script, Similarity Optimized Backtranslator (SOB), capable
of backtranslating amino acid sequences to DNA sequences of high similarity, which we used for
generating fusion proteins of BO and CO, through a gene shuffling method. Similarly, we
determined the opsin amino acids required for the specific interactions with the Lye homologs and
studied their localization using the reported opsin crystal structures. The two proteins had high
structural similarity in the identified regions, and, more importantly, all BO, CO, and Lye domains
required for inhibition were situated in a similar location, in the cytoplasmic section of the protein
between two transmembrane α-helices.
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Materials and Methods
Strains, plasmids, genes, and primers
H. volcanii strains and plasmids used in the study are listed in Table 1. Synthetic genes and
primers sequences are listed in Table 2. All primers were ordered from IDT (Coralville, IA).

Table 1. H. volcanii strains and plasmids used in this study
Name
Description
H1209
Δmrr, ΔpyrE2, ΔhdrB, pitA replaced with pitA from another organism
RFP58
H1209 ∆lye
RFP131
H1209 ∆lye::H. vallismortis lye
RFP152
H1209 ∆lye::H. salinarum lye
RFP181
H1209 Δlye::lye(Hsal 1-125, Hvol 152-301)
RPF182
H1209 Δlye::lye(Hsal 1-198, Hvol 225-301)
RFP188
H1209 Δlye::lye(Hsal 1-67, Hvol 94-301)
RFP192
H1209 Δlye::lye(Hsal 1-125, Hvol 152-301) with pRFP121 (empty
vector)
RFP193
H1209 Δlye::lye(Hsal 1-125, Hvol 152-301) with pRFP126 (bop
expression)
RFP194
H1209 Δlye::lye(Hsal 1-198, Hvol 225-301 )with pRFP121 (empty
vector)
RFP195
H1209 Δlye::lye(Hsal 1-198, Hvol 225-301) with pRFP126 (bop
expression)
RFP200
H1209 Δlye::lye(Hsal 1-67, Hvol 94-301) with pRFP121 (empty
vector)
RFP201
H1209 Δlye::lye(Hsal 1-67, Hvol 94-301) with pRFP126 (bop
expression)
pMPK408 Plasmid for H. salinarum gene replacements - has E. Coli vector with
ura3, MevR & polylinker
pTA131
H. volcanii integrative plasmid for generating knockouts
pTA963
H. volcanii overexpression plasmid
pRFP126 pTA963 – with bop for gene overexpression
pRFP128 pTA131 – plasmid to insert genes into the H. volcanii lye locus
pRFP147 pMPK408 – plasmid to insert genes into the H. salinarum lye locus
pRFP158 pRFP147 – lye(Hsal 1-125, Hvol 152-301)
pRFP177 pRFP147 – lye(Hsal 1-198, Hvol 225-301)
pRFP184 pRFP147 – lye(Hsal 1-67, Hvol 94-301)
pRFP237 pRFP128 – lye(Hsal 1-125, Hvol 152-301)
pRFP238 pRFP128 – lye(Hsal 1-198, Hvol 225-301)
pRFP241 pRFP128 – lye(Hsal 1-67, Hvol 94-301)
pRFP268 pUC57 – GS_bop
pRFP269 pUC57 – GS_cop3

Ref.
51

this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
52

53
51

this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
this study
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Table 2. DNA sequences of the synthetic genes and primers used in this study
Name
Sequence
GCCATGCCACTGGAATCTGCACATATGCTCGAGCTCCTCCCGACCGCGGTCGAGGGCGT
GS_bop

GS_cop3

RP183
RP246
RP268
RP269
RP273
RP274
RP275
RP276
RP277
RP278
RP279
RP410
RP449
RP450

CTCGCAGGCGCAGATCACCGGCCGCCCCGAGTGGATCTGGCTCGCGCTCGGCACCGCG
CTCATGGGCCTCGGCACGCTCTACTTCCTCGTGAAGGGCATGGGCGTGTCCGACCCGGA
CGCGAAGAAGTTCTACGCCATCACCACCCTCGTCCCCGCGATCGCGTTCACCATGTACC
TCTCGATGCTGCTCGGCTACGGCCTCACCATGGTCCCGTTCGGGGGCGAGCAGAACCCG
ATCTACTGGGCGCGCTACGCGGACTGGCTCTTCACCACCCCGCTCCTCCTCCTCGACCTC
GCCCTCCTCGTGGACGCGGACCAGGGCACCATCTTGGCGCTCGTCGGCGCCGACGGCAT
CATGATCGGCACCGGCCTCGTCGGGGCCCTCACGAAGGTCTACTCGTACCGCTTCGTCT
GGTGGGCCATCTCGACCGCGGCCATGCTCTACATCCTCTACGTCCTCTTCTTCGGCTTCA
CCTCGAAGGCGGAGTCGATGCGCCCGGAGGTCGCCTCGACCTTCAAGGTCCTCCGCAAC
GTCACCGTCGTCCTCTGGTCGGCCTACCCGGTCGTGTGGCTCATCGGCTCCGAGGGCGC
CGGCATCGTCCCCCTCAACATCGAGACCCTGCTCTTCATGGTCCTCGACGTCAGCGCGA
AGGTCGGCTTCGGCCTCATCCTCCTCCGCTCGCGCGCGATCTTCGGCGAGGCGGAGGCG
CCGGAGCCGTCGGCCGGCGACGGCGCGGCCGCGACCTCGGACTGAGAATTCCGATTCC
CAGAATGTAAGCGATTCCCAGAATGTAAG
GCCATGCCACTGGAATCTGCACATATGCCGGCGCCGGAGGGCGAGGCGATCTGGCTCT
GGCTCGGCACCGCGGGCATGTTCCTCGGCATGCTCTACTTCATCGCGAGGGGCTGGGG
CGAGACCGACTCGCGCCGCCAGAAGTTCTACATCGCCACCATCCTCATCACCGCGATC
GCGTTCGTCAACTACCTCGCGATGGCGCTCGGCTTCGGCCTCACCATCGTCGAGATCG
CGGGCGAGCAGCGCCCGATCTACTGGGCGCGCTACTCGGACTGGCTCTTCACCACCCC
GCTCCTCCTCTACGACCTCGGCCTCCTCGCGGGCGCGGACCGGAACACCATCTCGTCG
CTCGTCAGCCTCGACGTCCTCATGATCGGCACCGGCCTCGTCGCGACCCTCTCGGCGG
GCTCGGGCGTCCTCTCGGCGGGCGCGGAGCGCCTCGTCTGGTGGGGCATCTCGACCGC
GTTCCTGCTCGTCCTCCTCTACTTCCTCTTCTCCTCGCTCTCGGGCCGCGTCGCGGACCT
CCCGTCGGACACCCGCTCGACCTTCAAGACCCTCCGCAACCTCGTCACCGTCGTCTGGT
TGGTCTACCCGGTCTGGTGGCTCGTCGGCACCGAGGGCATCGGCCTCGTCGGCATCGG
CATCGAGACCGCGGGCTTCATGGTCATCGACCTCGTCGCGAAGGTCGGCTTCGGCATC
ATCCTCCTCCGCTCGCACGGCGTCCTCGACGGGGCGGCGGAGACCACCGGCGCCGGCG
CGACCGCGACCGCGGACTGAGAATTCCGATTCCCAGAATGTAAGCGATTCCCAGAATG
TAAG
AAAACATATGATGTTCCGGTATCTGTTCGTGT
AAAATCTAGACTTCGGGCTCGGCGTCTACTATC
CGCTCTCGAAGCTGTTTCTC
AAAAATGCGATGGTCCAGAG
AAAACATATGCCATTGACGAGCCTCCA
ACGGAGTACAGCGCACCCCCGTTTCGGTTCAAGACGA
GGGTGCGCTGTACTCCGT
TTCGACCGCGACGTCGACGAAGCGAACCCGAAGAAG
GTCGACGTCGCGGTCGAA
ACCACTGCGACCGCGCTGGGCGAGCGGCGGACCTA
CAGCGCGGTCGCAGTGGT
AAAAAGATCTTTAGCCATTGACGAGCCTCCA
CATGCCACTGGAATCTGCAC
GGGAATCGCTTACATTCTGGG
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Cultivation conditions
H. volcanii was grown at 40°C in Hv-YPC53 liquid medium or agar supplemented with
thymidine (40 μg/mL). Escherichia coli DH5α (New England Biolabs, Ipswich, MA) was grown
in LB medium or agar supplemented with ampicillin (50 μg/ml) at 37°C. Liquid cultures were
grown with shaking at 250 rpm.

Plasmid construction
The Lye fusion genes (pRFP158, pRFP177, pRFP184) were constructed by two-step PCR.
Firstly, Halobacterium sp. NRC-154 genomic DNA was used as template in PCR with primer pairs
RP275-RP246 (pRFP158), RP279-RP246 (pRFP177), RP277-RP246 (pRFP184) and Haloferax
sp. DS255 genomic DNA was used as template in PCR with primer pairs RP274-RP273
(pRFP158), RP278-RP273 (pRFP177), and RP276-RP273 (pRFP184). Secondly, the first step
PCR products were used as template with the primer pair RP246-RP273, and the resulting
amplicons were digested with XbaI and NdeI and ligated into the XbaI-NdeI fragment of pRFP147.
To construct the plasmids pRFP237, pRFP238, and pRFP241 for inserting the Lye fusion genes
into the genome of H. volcanii, plasmids pRFP158, pRFP177, and pRFI184, respectively, were
used as template in PCR with primer pair RP183-RP410. The PCR products were then digested
with NdeI and BglII and ligated into the NdeI-BglII 4 kb fragment of pRFP128.
Plasmids pRFP28, pRFP120, pRFP121, pRFP126, pRFP128, and pRFP147 were previously
constructed in the Peck lab. The vectors harboring the synthetic genes (pFP268, pRFP269) were
ordered from Genscript (Piscataway, NJ).
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Haloferax strain construction
The H. volcanii strains expressing Lye fusion proteins were constructed by integrating the lye
genes from plasmids pRFP237, pRFP238, and pRFP241 into the genome of the ∆lye strain RFP58
using a previously described gene replacement method53. Then, the resulting strains were
transformed with plasmid pRFP126 (and pTA963 as a control), which allows H. volcanii to
express H. salinarum bop (Peck et al., submitted), in order to form the corresponding strains
RFP192, RFP193, RFP194, RFP195, RFP200, and RFP201.

Structure prediction
The structural models for the two Lye homologs were created using Phyre2 intensive modeling
mode56 and superimposed with SuperPose57. Specific regions of the structures were highlighted
and the figures were exported to image files using Geneious.

Gene design, shuffling, and transformation
To increase the efficiency of gene shuffling, the genes encoding BO and CO were designed in
silico for high DNA sequence similarity. This was achieved by loading the amino acid sequences
of the two proteins in the SOB Python script we developed.
The ≈800 bp BamHI/XbaI fragments of pRFP268 and pRFP269 were gel-purified and PCRamplified using primers RP449 and RP450. Gene shuffling was performed on the obtained
amplicons as described in Meyer et al.58 with the following modifications. Phusion High-Fidelity
DNA Polymerase (New England Biolabs, Ipswich, MA) was used for all PCR steps. The library
amplification was performed using 20 µL of the elution reassembly product in four 50 µL PCR
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reactions with primer pair RP449-RP450, and the product (GS-library) of this reaction was PCRpurified and concentrated by vacuum centrifugation.
The NdeI-EcoRI digested GS-library was size reduced to 750-1100 bp through gel extraction
and ligated into the ≈8300 bp NdeI-EcoRI fragment of pRFP121. This library of plasmids
containing the shuffled genes was then transformed in E. coli competent cells, which were grown
overnight in a 200 mL culture, after a 1h recovery step. Plasmid DNA was extracted from the
culture and transformed into the RFP131 and RFP152 strains using the previously mentioned
protocol. The white transformed colonies were used for colony PCR to amplify and sequence the
shuffled gene (Eurofins Genmoics, Louisville, KY).

Colorimetric assay
Bacterioruberin levels of the strains expressing Lye fusion proteins were analyzed using a
colorimetric procedure (Peck et al., submitted). Colonies grown on Hv-YPC solid medium were
photographed in a reproducible manner and the pictures’ color properties (hue and saturation) were
used to determine a ruberin index, which represents a measure of the bacterioruberin to lycopene
ratio. A high ruberin index is correlated to a larger amount of bacterioruberin compared to lycopene
and indicates a low level of Lye inhibition.
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Results
Lye fusion
To determine the Lye amino acid region involved in the inhibitory interaction with BO, we
constructed hybrid genes by fusing parts of the lye homologs from H. salinarum and H. volcanii
and tested the encoded proteins for inhibition by BO. For this, we integrated the fusion genes into
the lye locus of H. volcanii, and we transformed an expression vector with or without bop. Then,
we used a colorimetric assay for comparing the bacterioruberin to lycopene ratio between the
strains expressing BO and those that were not, to determine which fusion proteins were inhibited
(Figure 3). The strains expressing fusion proteins H. sal 1-120 – H. vol 147-301 and H. sal 1-192
– H. vol 219-301 had a significantly reduced ruberin index when BO was co-expressed from
plasmid, indicating the presence of BO-Lye inhibition (Figure 3). Using these data, we determined
that inhibition was always present when the 69-120 region was from H. salinarum Lye (Figure 4).

Figure 3. Ruberin index for strains expressing different Lye proteins
in the presence and absence of BO. Permutation test. (*, p<0.05)
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Figure 4. Protein alignment map of the Lye homologs and three of their fusion proteins. The xaxes represent the amino acid positions in the corresponding homolog, the y-axes show the fusion
protein composition using residue numbering (left) and enzyme inhibition by BO (right), and the
vertical lines within the protein sequences represent gaps in the alignment. The dashed lines mark
the H. salinarum Lye region required for inhibition by BO.

Lye structure prediction
We generated template-based structure predictions of the two Lye homologs, and compared the
identified 52 amino acid region between the two models (Figure 5). Both Lye sequences aligned
to 4-hydroxybenzoate octaprenyltransferase with a confidence score of 100% and >85% coverage.
The validity of this structural prediction is further confirmed by the fact that both lycopene (Lye
substrate) and octaprenyl (4-hydroxybenzoate octaprenyltransferase substrate) are C40 molecules
with similar conjugated systems. Interestingly, the two protein models have a high structural
similarity for the 52 amino acid section of interest, with minor differences in the third TM domain
and second inter-helix coil. These differences are located in regions of low model confidence, due
to the presence of a disordered section. However, it is worth noting that the only significant region
of disorder in each homolog is located within the identified 52 amino acid section.
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Figure 5. Tertiary structure predictions of H. salinarum (left) and H.
volcanii (right) Lye. Colored regions represent the identified 52 amino acid
section of interest. Structures are depicted within the membrane and
oriented with the top side towards the extracellular environment.

Similarity optimized backtranslation
We studied the opsin domains required for Lye inhibition, by generating bop-cop fusion genes
using gene shuffling. This method starts with genes of high similarity and, through progressive
hybridization PCR, creates a library of randomly hybridized genes. To achieve the required initial
gene sequence similarity, we wrote a Python script (SOB) that takes as input an alignment of two
proteins and a specified codon usage (both files in comma separated values format) and returns a
file with corresponding DNA sequences of higher similarity compared to random codon usage.
SOB works by backtranslating the two proteins into the codon optimized genes, finding regions
of similarity, and then trying to extend them in both directions. More specifically, the algorithm
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performs pairwise comparisons of the two genes, starting at the first codon. If it finds a match
larger than 3 bp, it checks the codons before and after the match site for silent mutations that could
increase the similarity of the genes. When such a substitution is available, SOB changes the codons
accordingly and starts the process over. The algorithm is repeated until the sequences do not
change anymore, or when the maximum number of iterations set by the user is reached (Figure 6).

Figure 6. SOB proof of concept using a theoretical example. The first line displays
the aligned genes for the two proteins of interest, with the corresponding regions
of similarity highlighted in the red rectangles. Second and third lines represent the
DNA sequences after backtranslation and codon optimization, respectively. It can
be observed that similarity regions are extended in both directions at each step.
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The initial opsin genes, as sequenced from their native organisms, were 59% similar and had
23.5% gaps in the alignment. After the backtranslation step, the genes reached 69.1% similarity
and the gaps percentage reduced to 16.9%. And, after the codon optimization step, the output of
SOB consisted of two genes that were 73.3% similar and had 12% gaps in their alignment.59 More
importantly, SOB decreased the distances between the regions of identity in the alignment, thereby
increasing the length of similar regions and the probability of crossing-over during gene shuffling,
which subsequently increased the efficiency of our library generation (Figure 7).

Figure 7. Pairwise sequence identity of the bop and cop genes at different stages of the
optimization process. The rectangles highlight regions where there is a clear increase in sequence
similarity between the input and output of our algorithm.

Gene shuffling
To identify the corresponding opsin protein domains required for the studied inhibitory
interaction, we chose a fusion protein approach, similar to the one used for the Lye experiments.
We used the bop and cop sequences optimized by SOB to generate a library of diverse hybrid
genes, which was transformed in H. volcanii strains expressing H. salinarum or H. vallismortis
Lye, and then we screened for constructs that inhibited either of the two homologs. Inhibition was
considered present when colonies were closer in color to cream than to pink (Figure 8). Ruberin
indices are currently being determined for the identified strains of interest.
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Figure 8. Representative picture of colonies from two strains expressing
different opsin fusion proteins. Due to the cream color, the colony on
the right was considered to exhibit Lye inhibition by the fusion opsin.

Using the color phenotype, candidate colonies were selected for screening. Their opsin genes
were amplified using colony PCR and then sequenced. The sequences were aligned against both
opsins to determine the gene’s identity. For H. salinarum Lye, we determined that inhibition
always occurred when amino acids 115 and 116 (Valine and Aspartate in BO and Alanine and
Glycine in CO) were from BO. Inhibition was still present when any of the other regions of the
protein was individually switched for the corresponding CO domain (Figure 9). Similarly, we
observed H. vallismortis Lye inhibition whenever two specific domains (27-69 and 102-135) of
CO were present in the fusion protein. Using the protein alignment, we further narrowed down the
second region to 108-130, based on amino acid matches between the proteins. Individually, the
origin of all the other regions, or their presence in some cases, was not observed to be important
for inhibiting the H. vallismortis Lye homolog. An interesting result is that some of the constructs
had a higher frequency in our screen than others (Supplementary Table 1).
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Figure 9. Protein alignment map of opsin fusions that inhibited H. salinarum Lye. X-axis
represents alignment amino acid position, y-axes show protein names (left) and their
inhibition of Lye (right), and blank sections represent alignment gaps. The dashed lines mark
the opsin region required for H. salinarum Lye inhibition.

Figure 10. Protein alignment map of opsin fusions that inhibited H. vallismortis Lye. X-axis
shows alignment amino acid position, y-axes show protein names (left) and their inhibition
of Lye (right), blank sections represent alignment gaps, and red lines show substitutions. The
dashed lines mark the opsin regions required for H. vallismortis Lye inhibition.
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Opsin structure comparison
To further study the opsin-Lye interaction, we mapped the identified regions from the gene
shuffling experiment onto the previously reported crystal structures of the two protein complexes
(Figures 11-12).

Figure 11. Tertiary structures of BR60 (left) and cR15 (right). Colored
regions represent the identified two amino acid section required for H.
salinarum Lye inhibition. Structures are depicted within the membrane and
oriented with the top side towards the extracellular environment.

We found a high degree of structural similarity between the two opsins in the sections required
for H. vallismortis Lye inhibition. The differences between homologs for all three identified
regions consisted of small sections of disorder. It is worth noting that the regions required for the
Lye interaction include cytoplasmic domains situated between two TM α-helixes, similarly to the
previously described Lye regions required for inhibition.
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Figure 12. Tertiary structures of BR60 (left) and cR15 (right). Colored regions
represent the identified 43 and 34 amino acid sections required for H.
vallismortis Lye inhibition. Structures are depicted within the membrane and
oriented with the top side towards the extracellular environment.
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Discussion
Lycopene elongase
Lye catalyzes the conversion of lycopene to tetrahydrobisanhydrobacterioruberin as its main
primary function. Recent results suggest that the protein also has a regulatory role in the
biosynthesis of retinal through its inhibition by opsins. To further characterize this recently
discovered interaction and determine the Lye protein domains involved in it, we generated fusion
proteins from the H. salinarum and H. volcanii homologs and tested their inhibition by BO.
With this approach, we localized a domain required for inhibition within a 52 amino acid region
of Lye. While the data have not confirmed this section to be sufficient to confer a Lye homolog
the ability to be inhibited by BO, the results indicate that the 69-120 region of H. salinarum Lye
is necessary for this interaction to occur. Future studies will test a fusion protein consisting of H.
volcanii Lye with the identified 52 amino acid domain from the H. salinarum homolog. If this
construct is inhibited by BO, the inhibitory interaction can be confidently localized to the identified
region. Moreover, to increase the resolution of our search for the amino acids involved in this
inhibitory interaction, we plan on performing gene shuffling experiments with the two Lye
homologs.
The structure prediction studies revealed interesting features of the identified region of interest.
Firstly, the 52 amino acid section presents high structural similarity between the two Lye
homologs, indicating that the region required for inhibition may be further narrowed down.
Secondly, this domain of interest seems to include the only significant section of disorder in each
of the proteins. Disordered domains are sections of proteins that lack a fixed structure, but which
are often functionally important. Lastly, the identified region spans both part of the third TM helix
and the cytoplasmic side, raising the possibility that the inhibition takes places at the interface
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between the lipid bilayer and the cytoplasm, which is further strengthened by the fact that BO is
an integral membrane protein.
Taken together, the fusion protein analysis along with the structure prediction results suggest
that the amino acids involved in H. salinarum Lye’s inhibition by BO reside within the 69-120
domain. Nevertheless, it might be the case that the predicted model is somewhat different than the
3D structure of the protein and that the interaction does not require specific amino acid residues,
but rather a certain overall tertiary structure. Such limitations are inherent to our experimental
design and weaken the confidence of our results, but they will be addressed in the future Lye
shuffling experiments.

SOB and gene shuffling
Gene shuffling is a high-throughput method for generating a library of hybrid genes. The key
parameter that determines the diversity and size of the library is the similarity of the starting genes.
In order to increase the efficiency of our shuffling, we wrote a script for backtranslating two
aligned protein sequences to high similarity DNA sequences. The tested peptides (Figure 6)
confirmed the ability of our algorithm to find matching sections ≥ 3 bp and extend them in both
directions by optimizing codon usage for higher similarity. However, despite its proper
functioning, we are aware of the many limitations SOB has as a potential bioinformatics tool.
One such limitation is the limited accessibility, evident in the lack of a user-friendly interface
and in the input requirement for an alignment of the two proteins in a specific format. These
features can be improved by having the script read multiple file formats, and perform its own
protein alignment using an online tool like BLASTP61. Furthermore, currently, SOB is not
guaranteed to output the two most similar DNA sequences given any two proteins. At the expense
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of computational time, the script could start the algorithm from any position on the alignment not
just from the first codon, and it could also search for any codon changes that increase sequence
similarity, not just those that extend previous regions of identity. Such modifications, along with
expanding the backtranslation process to include all possible codon usage rankings, would
significantly increase the probability that the algorithm finds the global minimum (the two DNA
sequences of highest similarity) as opposed to a local minimum.
Nevertheless, despite the limitations of our script, SOB has proved effective in generating a
diverse library of fusion proteins (Supplementary Table 1). Based on the frequency of the
sequenced shuffled opsins, it is clear that, at least for the proteins that inhibited Lye, there was a
bias towards a BO N-terminus or a CO middle section (Figures 9,10). We believe that these results
can be explained by the high similarity terminal regions of the two proteins, which had a higher
probability of cross-over than the rest of the peptide.

Bacterioopsin and cruxopsin
In the cell, bacterioopsin and cruxopsin covalently bind retinal to form the light-driven proton
pumps BR and cR, respectively, which convert light energy to chemical energy. Apart from this
important function, the two opsins also play a role in retinal biosynthesis by inhibiting Lye, the
enzyme that catalyzes the committed step in bacterioruberin synthesis. This interaction represents
a recently described regulatory mechanism aimed at maintaining the appropriate ratio of
apoprotein to cofactor. Using gene shuffling, we studied the protein regions, from both BO and
CO, involved in this observed interaction with Lye. However, the inhibition screen was performed
using solely colony color, and the bacterioruberin levels were not yet confirmed by the colorimetric
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assay used in the previous experiments. As such, these conclusions are less convincing than the
ones regarding the Lye domains required for BO mediated inhibition.
Our results localized the BO amino acids required for inhibiting H. salinarum Lye to V115 and
D116. The corresponding CO amino acids are A115 and G116, which suggests that the studied
interaction might be ionic in nature. More interestingly, these two amino acids were localized in a
cytoplasmic inter-TM region, which strengthens the hypothesis that the inhibitory interaction
occurs at the interface between the membrane and the cytoplasm. Nevertheless, our data did not
validate the two amino acids as the only ones necessary for inhibition, a hypothesis that remains
to be tested in future studies.
The screen for H. vallismortis Lye inhibiting opsins was not as successful in localizing the
necessary region for interaction as the H. salinarum Lye screen, since it narrowed down the search
to two regions of 34 and 43 amino acids, as opposed to only one. This difference was likely due to
the lower number of screened colonies for H. vallismortis Lye inhibition, compared to that for the
inhibition of the H. salinarum homolog. Nonetheless, these domains exhibited high structural
similarity between the two opsins, and also included cytoplasmic inter-TM regions.
It is worth mentioning that all the identified opsin and Lye protein regions required for the
inhibitory interaction are situated within the same general location, in the cytoplasmic side of the
protein between two TM regions (Figure 13). This suggests that the opsin and Lye proteins could
come in close proximity to each other and have a direct inhibitory interaction leading to
bacterioruberin biosynthesis inhibition and higher levels or retinal. Future research could test this
hypothesis through co-immunoprecipitation and crystallization experiments.
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Figure 13. Structure comparison between the opsins and Lye homologs. The colored regions
represent the identified sections required for inhibition (left – H. salinarum Lye inhibition; middle
– H. vallismortis Lye inhibition; right – BO inhibition), while the red circles show the potential
interaction sites. Proteins are depicted within the membrane and oriented with the top side towards
the extracellular environment.

Conclusions
Overall, our analysis identified specific domains of the studied proteins that were required for
the opsin-Lye inhibitory interaction. Future directions will focus on determining the exact protein
regions responsible for this regulatory mechanism. With the information provided in this study,
fusion proteins can be specifically designed to test the identified regions, and amino acid
substitutions could more precisely localize the interacting amino acids. Lastly, a bioinformatics
study can be performed to identify similar domains in other biological systems and potentially
elucidate the mechanisms responsible for the regulation of apoprotein-cofactor stoichiometry.
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Supplementary Information
Supplementary Table 1. Structural composition of the shuffled genes. S1-S5 are the sequences
displayed in Figure 9, while SU1- SU3 are unused sequences. V1-V3 are the sequences displayed
in Figure 10, while UV1 is an unused sequence. In each of the two screens, one of the sequencing
reactions did not work.
Id
S1
S2
S3

BO aa
1-263
1-252
1-5; 114-117;
126-187;

CO aa
264-268
256-268
118-125

S4

1-107; 115117; 210-239
32-76; 81-96;
108-191; 203224; 261-268
1-268
1-260

108-114; 118209; 240-268
6-31; 77-80;
97-107; 192202; 225-260

S5

SU1
SU1
SU3
V1
V2
V3

1-26; 246-268
158-268
46; 71-101

VU1 77-117; 253263

261-268
6-73
27-245
6-117; 119-157
6-45; 47-69;
102-135
6-76; 118-213;
218-253; 264268

Frequency Comments
25%
16.7%
3 amino acid gap
5%
Frameshift after 187, contains the
following non-opsin amino acids:
RPSRPSATSSPSSGRPTRSCGSSAP
RAPASSPSTSRPCSSWSSTSARWR
SASASSSSARARSSARRRRRSRRP
ATARPRPRTENSCSPGDPLVLER
1.7%
More pink than others, but still creamcolored
1.7%

45%
1.7%
1.7%
73.3%
6.7%
6.7%
6.7%

Inexplicable cream color phenotype.
Probably due to an unknown mutation.
Position 118 is W (Q in BO, R in CO)

Very pink. Insert of ADADHDA
between positions 213 and 218; aa 253
counted twice because protein has D
(253 in CO) and E (253 in BO)
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Supplementary Data 1. SOB source code
#Author: Alex Pleşa
#Project: Gene shuffling
#Date: 9/15/16

###Read alignment
alignment <- read.csv(file="Alignment.csv",head=TRUE,sep=",")
alignment <- data.frame(lapply(alignment, as.character), stringsAsFactors=FALSE)

###Read genetic code
genCode <- read.csv(file="genCode.csv",head=TRUE,sep=",")
genCode <- data.frame(lapply(genCode, as.character), stringsAsFactors=FALSE)

###Create data frames for all sequences
gene1_seq<- matrix(,nrow=1,ncol=3*length(alignment[,1]))
gene2_seq<- matrix(,nrow=1,ncol=3*length(alignment[,2]))

###Generate first DNA sequence
variant_g1<-""
for(i in 1:length(alignment[,1])){
if(is.na(alignment[i,1])){
variant_g1 = paste(variant_g1," ",sep="")
}
else{
variant_g1 = paste(variant_g1,genCode[2,grep(alignment[i,1],colnames(genCode))],sep="")
}
}
for(i in 1:nchar(variant_g1)){
gene1_seq[i]=substr(variant_g1,i,i)
}
colnames(gene1_seq)=1:as.numeric((3*length(alignment[,1])))

###Generate second DNA sequence
variant_g2<-""
for(i in 1:length(alignment[,2])){
if(is.na(alignment[i,2])){
variant_g2 = paste(variant_g2," ",sep="")
}
else{
variant_g2 = paste(variant_g2,genCode[2,grep(alignment[i,2],colnames(genCode))],sep="")
}
}
for(i in 1:nchar(variant_g2)){
gene2_seq[i]=substr(variant_g2,i,i)
}
colnames(gene2_seq)=1:as.numeric((3*length(alignment[,2])))
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###Similarize the sequences
iteration=0; #intialize variable that counts the iterations
repeat{ #repeat this until nothing changes anymore or it has hit the max iterations
stop=0;#nothing changed
start=0;
end=0;
iteration=iteration+1;
for(i in 1:length(gene1_seq)){ #loop through the genes
if(gene1_seq[i]==gene2_seq[i]){ #if the nucleotides are the same
if(start==0){ #if start is not set, set it here
start=i;
}
end=i; #make this the end of the island
}
else {
if((end-start)>=2){ #if length is larger than 3 bp
changed=change(gene1_seq,gene2_seq,start,end);#see if you can exchange any codons to increase similarity
if(changed[1]!=0){
gene1_seq[changed[2]]=substr(genCode[changed[5]+1,changed[3]],1,1);
gene1_seq[changed[2]+1]=substr(genCode[changed[5]+1,changed[3]],2,2);
gene1_seq[changed[2]+2]=substr(genCode[changed[5]+1,changed[3]],3,3);
gene2_seq[changed[2]]=substr(genCode[changed[6]+1,changed[4]],1,1);
gene2_seq[changed[2]+1]=substr(genCode[changed[6]+1,changed[4]],2,2);
gene2_seq[changed[2]+2]=substr(genCode[changed[6]+1,changed[4]],3,3);
stop=1;#something changed
}
if(changed[7]!=0){
gene1_seq[changed[8]]=substr(genCode[changed[11]+1,changed[9]],1,1);
gene1_seq[changed[8]+1]=substr(genCode[changed[11]+1,changed[9]],2,2);
gene1_seq[changed[8]+2]=substr(genCode[changed[11]+1,changed[9]],3,3);
gene2_seq[changed[8]]=substr(genCode[changed[12]+1,changed[10]],1,1);
gene2_seq[changed[8]+1]=substr(genCode[changed[12]+1,changed[10]],2,2);
gene2_seq[changed[8]+2]=substr(genCode[changed[12]+1,changed[10]],3,3);
stop=1;#something changed
}
}
start = 0; #set start and end to 0
end = 0;
}
if((i==end)&&(end==length(gene1_seq))&&(start!=1)){ #special case for C terminus
changed=change(gene1_seq,gene2_seq,start,end);#see if you can exchange any codons to increase similarity
if(changed[1]!=0){
gene1_seq[changed[2]]=substr(genCode[changed[5]+1,changed[3]],1,1);
gene1_seq[changed[2]+1]=substr(genCode[changed[5]+1,changed[3]],2,2);
gene1_seq[changed[2]+2]=substr(genCode[changed[5]+1,changed[3]],3,3);
gene2_seq[changed[2]]=substr(genCode[changed[6]+1,changed[4]],1,1);
gene2_seq[changed[2]+1]=substr(genCode[changed[6]+1,changed[4]],2,2);
gene2_seq[changed[2]+2]=substr(genCode[changed[6]+1,changed[4]],3,3);
stop=1;#something changed
}
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}
}
if((stop==0)||(iteration==1000)){#if nothing changed, don't repeat
break
}
}

###Function that finds alternative codon pairings to increase sequence identity
change <- function(gene1, gene2, start, end){
s_c = ceiling((start-1)/3)*3-2; #get the position of the codon before the island
s_c1 = paste(gene1[s_c],gene1[s_c+1],gene1[s_c+2],sep=""); #get gene 1 first mismatched codon before island
s_c2 = paste(gene2[s_c],gene2[s_c+1],gene2[s_c+2],sep=""); #get gene 2 first mismatched codon before island
s_a1_col = grep(s_c1,genCode); #get column of AA of gene1 of first mismatched codon before island
s_a2_col = grep(s_c2,genCode); #get column of AA of gene2 of first mismatched codon before island
e_c = ceiling((end+1)/3)*3-2; #get the position of the codon after the island
e_c1 = paste(gene1[e_c],gene1[e_c+1],gene1[e_c+2],sep=""); #get gene 1 first mismatched codon after island
e_c2 = paste(gene2[e_c],gene2[e_c+1],gene2[e_c+2],sep=""); #get gene 2 first mismatched codon after island
e_a1_col = grep(e_c1,genCode); #get column of AA of gene1 of first mismatched codon after island
e_a2_col = grep(e_c2,genCode); #get column of AA of gene2 of first mismatched codon after island
#variable that signals if anything has changed and stores values for changing codons
changed <- c(0,s_c,s_a1_col,s_a2_col,0,0,0,e_c,e_a1_col,e_a2_col,0,0);
#Find most similar codons in the 2 columns for the 1st mismatched codon before island
if(start!=1){#if the start of the island is not on the first bp, check on the left
score <- matrix(0L,nrow=as.numeric(genCode[1,s_a1_col]),ncol=as.numeric(genCode[1,s_a2_col]));#score
matrix for all codon combinations
for(i in 1:as.numeric(genCode[1,s_a1_col])){ #loop through first AA codon posibilities
c1=genCode[i+1,s_a1_col];
for(j in 1:as.numeric(genCode[1,s_a2_col])){ #loop through second AA codon posibilities
c2=genCode[j+1,s_a2_col];
score[i,j]=get_score(1,c1,c2);
}
}
if(max(score)>get_score(1,s_c1,s_c2)){ #replace codons with 1st pair if more similar than previous pair
inds = which(score==max(score), arr.ind=TRUE);
changed[1]=1; #there is an alternative
changed[5]=inds[1,1]; #codon position for gene 1
changed[6]=inds[1,2]; #codon position for gene 2
}
}
#Find most similar codons in the 2 columns for the 1st mismatched codon after island
if(end!=length(gene1)){
#score matrix for all codon combinations
score <- matrix(0L,nrow=as.numeric(genCode[1,e_a1_col]),ncol=as.numeric(genCode[1,e_a2_col]));
for(i in 1:as.numeric(genCode[1,e_a1_col])){ #loop through first AA codon posibilities
c1=genCode[i+1,e_a1_col];
for(j in 1:as.numeric(genCode[1,e_a2_col])){ #loop through second AA codon posibilities
c2=genCode[j+1,e_a2_col];
score[i,j]=get_score(2,c1,c2);
}
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}
if(max(score)>get_score(2,e_c1,e_c2)){ #replace codons with 1st pair if more similar than previous pair
inds = which(score==max(score), arr.ind=TRUE);
changed[7]=1; #there is an alternative
changed[11]=inds[1,1]; #codon position for gene 1
changed[12]=inds[1,2]; #codon position for gene 2
}
}
return (changed);
}

###Function that returns the similarity score of 2 codons
get_score <- function(type,c1,c2){
s = 0;
if(type==1){
for(k in 3:1){ #loop through codon positions from righ to left
if(substr(c1,k,k)==substr(c2,k,k)){ #if they match increase score by k
s=s+k*k;#scoring scheme is 3rd nucletodies match=9; 2nd nucleotides match=4, 1st nucleotides match=1
}
}
}
else{
for(k in 1:3){ #loop through codon positions from left to right
if(substr(c1,k,k)==substr(c2,k,k)){ #if they match increase score by k
s=s+9/k/k;#scoring scheme is 1st nucletodies match=9; 2nd nucleotides match=9/4, 3rd nucleotides match=1
}
}
}
return (s);
}

#Write the two genes to a .txt file
sink("output.txt")
cat(as.character(colnames(alignment[1])))
cat(">\n")
cat(paste(gene1_seq,sep="",collapse=""))
cat("\n\n")
cat(as.character(colnames(alignment[2])))
cat(">\n")
cat(paste(gene2_seq,sep="",collapse=""))
sink()

